Predictive Analytics + AI
Spectral
MD Holdings, Ltd. was established through the technology transfer department of
the University of Texas Southwestern with its operating subsidiary being
incorporated in the State of Delaware, U.S., in 2009. The Group’s initial focus
was to provide clinicians with the ability to understand and predict pressure
ulcers for bed-ridden patients. From 2013 to 2021, the Group engaged in
Biomedical Advanced Research and Development Authority (BARDA) contracts to
investigate the use of its technology as a surgical-triage tool for burn
victims in a mass casualty event. In 2018, the FDA designated the
DeepView® technology with Breakthrough Device for its burn indication.
Latest Share Price
-
-
-
Investor Alerts